FIELD: biotechnologies.
SUBSTANCE: invention describes the methods of determination of: Aβ(1-17) peptide in a sample; whether a subject has a moderate form of Alzheimer's disease; whether a subject has a moderate cognitive disorder with a prodromal form of Alzheimer's disease and monitoring of Alzheimer's disease. The methods include determination of action or level of Aβ(1-17) peptide on the basis of amount of the revealed marker.
EFFECT: invention represents the methods allowing to distinguish patients with moderate form of Alzheimer's disease, with prodromalny form with non-prodrom moderate cognitive disorder, with non-prodrom moderate cognitive decrement.
8 cl, 6 dwg, 3 tbl, 4 ex
| Title |
Year |
Author |
Number |
| HIGH-SENSITIVITY IMMUNOASSAYS AND KITS FOR DETECTING PEPTIDES AND PROTEINS OF INTEREST |
2007 |
- Sarasa Barrio Kh Manuehl'
|
RU2461837C2 |
| MONOCLONAL BODY AGAINST AMYLOID BETA |
2008 |
- Andrea Pfajfer
- Marija Pil'Gren
- Andreas Mus
- Rajan Uotts
|
RU2571856C2 |
| METHOD OF TREATING ALZHEIMER'S DISEASE |
2009 |
|
RU2526155C2 |
| METHODS AND REAGENTS FOR IMPROVEMENT OF DETECTING AMYLOID BETA-PEPTIDES |
2010 |
- Sarasa Barrio Khose Manuehl'
|
RU2554774C2 |
| BETA-AMYLOID ANTIBODIES |
2013 |
- Groves, Maria
- Gustavsson, Suzanne
- Hoglund, Kina
- Lowne, David
- Lloyd, Chris
- Nickson, Adrian
- Niva, Camilla
- Simon, Sylvia
|
RU2689674C2 |
| METHOD FOR IN VITRO DIAGNOSIS OF ALZHEIMER'S DISEASE USING MONOCLONAL ANTIBODY |
2006 |
|
RU2416619C2 |
| COMPOSITION CONTAINING ANTIBODY AGAINST ABETA PROTOFIBRILS AND INHIBITOR OF BETA-SECRETASE BACE1 FOR TREATMENT OF ALZHEIMER'S DISEASE |
2017 |
- Satlin, Andrew
- Fukushima, Tatsuto
|
RU2786476C2 |
| PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE |
2013 |
|
RU2696566C2 |
| APPLICATION OF OXYCAM COMPOUNDS |
2004 |
|
RU2366425C2 |
| PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF ALZHEIMER-TYPE DEMENTIA |
2013 |
|
RU2811687C2 |
